Explore comprehensive strategies for treatment-resistant depression, including augmentation options, ketamine therapy, and brain stimulation techniques.
The FDA's Purple Book is the official guide to biosimilars and interchangeable biological drugs. Learn how it works, what the difference is between biosimilars and interchangeable products, and how pharmacists use it to make safe substitutions.
Discover how time-to-onset patterns vary by drug class. Learn when to expect side effects for antibiotics, statins, and ACE inhibitors, and why timing is key to accurate diagnosis.
Explore the rise of direct-to-consumer generic pharmacies and how new business models are bypassing PBMs to lower drug prices and improve patient access.
A comprehensive guide for pharmacists on documenting generic drug substitutions, covering state laws, NTI drugs, and electronic record-keeping best practices.
Not all generic medications work the same for everyone. While FDA-approved as bioequivalent, small differences in inactive ingredients and absorption can cause serious reactions in some patients-especially with narrow therapeutic index drugs like levothyroxine and warfarin.